English | Español

Allergan, Inc.
Ruth de Jauregui | Apr 22, 2017

Novartis teaming with Allergan in Phase IIb trial of non-alcoholic steatohepatitis treatment therapy
Tabitha Fleming | Jan 24, 2017

Allergan continues support for headache research

Jamie Barrand | Mar 20, 2016

New treatment available for bipolar disorder, schizophrenia
Jamie Barrand | Mar 17, 2016

Allergan's dry eye disease therapy receives prior approval supplement from FDA
Jamie Barrand | Dec 17, 2015

Allergan releases new therapy for irritable bowel syndrome
Jamie Barrand | Dec 7, 2015

Allergan partners with Rugen Therapeutics to develop autism, OCD therapies
Jamie Barrand | Oct 16, 2015

Amgen, Allergan launch Phase 3 study of biosimilar candidate ABP 215
Jamie Barrand | Oct 14, 2015

Allergan releasing generic version of Invega in U.S.

Trending
+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas
Patient Daily | Jul 25, 2025

Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'
Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval